COLTENE Holding AG (SWX:CLTN)
48.15
-0.80 (-1.63%)
Jun 4, 2026, 5:30 PM CET
COLTENE Holding AG Market Cap
COLTENE Holding AG has a market cap or net worth of 287.72 million as of June 4, 2026. Its market cap has decreased by -25.58% in one year.
Market Cap
287.72M
Enterprise Value
313.97M
Revenue
240.05M
Ranking
n/a
PE Ratio
19.26
Stock Price
48.15
Market Cap Chart
Since June 23, 2006, COLTENE Holding AG's market cap has decreased from 435.24M to 287.72M, a decrease of -33.90%. That is a compound annual growth rate of -2.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 292.50M | -8.85% |
| Dec 30, 2025 | 320.88M | 4.48% |
| Dec 30, 2024 | 307.13M | -28.21% |
| Dec 29, 2023 | 427.85M | -6.04% |
| Dec 30, 2022 | 455.33M | -32.21% |
| Dec 30, 2021 | 671.65M | 30.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 247.05B |
| Novartis AG | 206.85B |
| Galderma Group AG | 38.56B |
| Lonza Group AG | 34.67B |
| Basilea Pharmaceutica AG | 614.83M |
| DocMorris AG | 345.45M |
| IVF Hartmann Holding AG | 292.91M |
| Newron Pharmaceuticals | 248.98M |